Form 4: U.S. Physical Therapy Director Sells Shares in Open Market Transaction
SEC Form 4 Filing
Nancy Ham, a director at U.S. Physical Therapy Inc., sold 1,172 shares of common stock at an average price of $96.72 on November 8, 2024.
Summary
- Nancy Ham, a director of U.S. Physical Therapy Inc., sold 1,172 shares of the company's common stock on November 8, 2024.
- The sale was executed at a weighted average price of $96.72 per share.
- The prices for the shares sold ranged from $96.68 to $96.81 per share.
- Following the transaction, Ms. Ham directly owns 1,112 shares of U.S. Physical Therapy Inc.
- This includes 712 shares of restricted stock granted under the company's 2003 Stock Incentive Plan.
- The restrictions on 356 of these shares will lapse on January 1, 2025, and another 356 will lapse on April 1, 2025, contingent on her continued service as a director.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. There is no indication of positive or negative sentiment, it is a neutral event.
Industry Context
This is a routine filing related to insider trading activity and is common for publicly traded companies. It does not indicate any specific trend in the physical therapy industry.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their insiders.
- The sale of shares by a director is a common occurrence and does not necessarily indicate a negative outlook for the company.
- Similar filings can be observed across the healthcare sector, including companies like Select Medical Holdings Corporation (SEM) and Encompass Health Corporation (EHC).
Stakeholder Impact
- The sale of shares by a director may have a minor impact on shareholder sentiment, but is not expected to significantly affect the company's operations or financial health.
Key Dates
| Date | Description |
|---|---|
| 11/08/2024 | Date of the stock sale transaction by Nancy Ham. |
| 01/01/2025 | Date when restrictions lapse on 356 shares of restricted stock. |
| 04/01/2025 | Date when restrictions lapse on another 356 shares of restricted stock. |
Keywords
insider trading, stock sale, Form 4, USPH, U.S. Physical Therapy, Nancy Ham, director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.